Nonoperative Treatment of Dorsally Dislocated Distal Radius Fractures in Adults With an Individualized 3D Printed Brace.

February 20, 2019 updated by: VieCuri Medical Centre

Nonoperative Treatment of Dorsally Dislocated Distal Radius Fractures in Adults With an Individualized 3D Printed Brace; a Tolerability Study in Healthy Volunteers and Patients (DRFB)

Study design: Two consecutive prospective case series. Study population: Part 1 will enroll 10 healthy volunteers (50 years or older). Part 2 will enroll 10 elderly patients (50 years or older) with a dorsally displaced distal radius fracture (AO type 23-A-C) that is acceptably reduced. In both parts, participants should have no restrictions in activities of daily living pre-fracture and no evident anatomical difference between both wrists.

Intervention:

Part 1: Participants will wear the brace continuously for one week. Part 2: Participants will wear the brace as treatment of the fracture for five weeks (instead of a plaster cast).

Main study parameters/endpoints: In parts 1 and 2, the primary outcome measure will be a Visual Analog Scale (VAS) score for wearing comfort. Secondary outcome measures are the occurrence of fracture redislocation (part 2 only), pain (VAS), inconvenience during NL61002.078.17 / DRFB-Tolerability Distal Radius Fracture Brace Tolerability Version number: 1.1, d.d. April 24, 2017 8 of 34 activities of daily living (Katz Index), and adverse reactions like pain, skin pressure, skin irritation/redness, sensibility issues, or device-related problems.

Study Overview

Status

Completed

Conditions

Detailed Description

Rationale: Each year, approximately 34,500 adults in The Netherlands sustain a fracture of the distal radius (wrist fracture). Incidence peaks in the elderly. The currently preferred treatment is closed reduction and nonoperative treatment by immobilization in a plaster cast for 4-6 weeks. Surgery is only performed if closed reduction fails or redislocation occurs. Plaster immobilization is inconvenient and interferes with daily activities. More importantly, standard nonoperative treatment often fails; in 40-60% of the fractures, redislocation requires surgery. Surgical treatment is about 9 times more expensive than nonoperative treatment and not without risks. This project aims to develop an innovative nonoperative treatment option. The central idea is to produce a 3D-printed brace for the fractured wrist using a mirrored CT-scan of the contralateral, unfractured wrist as a model. This innovative approach has the advantage that it does not depend on surgery and provides a better and potentially more durable positioning than the currently applied plaster cast. We expect that redislocation will occur less frequently, so surgery may be avoided. In contrast to a traditional plaster cast, the newly developed brace is water resistant/repellant, lighter, and enables movement of the hand. It enables daily activities and improves independency in the elderly with a wrist fracture. The treatment has been successfully evaluated in an ex vivo model. The clinical implementation will follow a step-wise approach.

Objective: Part 1 aims to determine the tolerability of the 3D-printed brace when worn by healthy volunteers (50 years of order), performing their normal daily activities. In part 2, the objective is to determine tolerability of the 3D-printed brace in patients (50 years or older) with an extra-articular distal radius fracture with dorsal displacement, performing their normal daily activities.

Study Type

Interventional

Enrollment (Actual)

15

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Limburg
      • Venlo, Limburg, Netherlands, 5912 BL
        • VieCuri MC

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

48 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

Part 1:

  1. Age 50 years or older
  2. Healthy volunteer without distal radius fracture
  3. No restrictions in activities of daily living prior to enrolment*
  4. Signed informed consent by participant * Participant should exercises complete self-control over urination and defecation, but use of incontinence material is allowed.

Part 2:

  1. Patients (50 years or older) with an acute**, unilateral distal radius fracture with dorsal displacement (AO type 23-A, B, or C) that is acceptably reduced (by simple closed reduction with vertical longitudinal traction)
  2. No restrictions in activities of daily living pre-fracture*
  3. Signed informed consent by patient

    • Participant should exercises complete self-control over urination and defecation, but use of incontinence material is allowed. ** Patients should report to the Emergency Department within 48h post-trauma.

Exclusion Criteria:

Part 1:

  1. Preexisting anatomical deviation of the ipsi- or contralateral wrist
  2. Conditions that affect function of the wrist or hand
  3. Insufficient comprehension of the Dutch or language to understand the study documents
  4. Participant unwilling or unable to comply with the study protocol and follow-up visit schedule
  5. Known allergy for brace material (PLA or alternative)

Part 2:

  1. Preexisting anatomical deviation of the ipsi- or contralateral wrist
  2. Additional traumatic injuries that affect treatment, rehabilitation, or function of the affected hand
  3. Pathological, recurrent, or open fracture
  4. Impaired wrist function pre-trauma at either wrist (e.g., arthrosis, rheumatoid disorder, or neurological disorder)
  5. Bone disorder that may impair bone healing, excluding osteoporosis
  6. Patient unwilling or unable to comply with the treatment protocol and follow-up visit schedule
  7. Insufficient comprehension of the Dutch language to understand the study documents
  8. Known allergy for brace material (PLA or alternative).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Healthy volunteers
All volunteers wore the DRFB
The distal radius fracture brace is constructed from biocompatible materials (like polylactic acid; PLA) and the skin is protected by commercially available and approved waterproof padding (like Aquacast®). The major brace components are connected and reinforced with carbon rods and plastic bolt-nut connections. PLA is extensively used, for example in surgical implants, but also as biological alternative for plastics. Aquacast® is approved and used as waterproof padding in swim plaster. The biomechanical function of the distal radius brace has been tested successfully in an ex vivo setting (results to be published). The DRFB includes the distal forearm, wrist an base of the hand. The thumb and fingers are free and the DRFB provides more movement than classical casting.
Experimental: Patients with DRF
All patients wore the DRFB
The distal radius fracture brace is constructed from biocompatible materials (like polylactic acid; PLA) and the skin is protected by commercially available and approved waterproof padding (like Aquacast®). The major brace components are connected and reinforced with carbon rods and plastic bolt-nut connections. PLA is extensively used, for example in surgical implants, but also as biological alternative for plastics. Aquacast® is approved and used as waterproof padding in swim plaster. The biomechanical function of the distal radius brace has been tested successfully in an ex vivo setting (results to be published). The DRFB includes the distal forearm, wrist an base of the hand. The thumb and fingers are free and the DRFB provides more movement than classical casting.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
VAS score
Time Frame: Day 1, day 3 and 7 for part 1. Week 1, week 2 and week 5 for part 2
the primary outcome measure will be the change in 1 week (part 1) and over several weeks (part 2) on a 10-centimeter Visual Analog Scale (VAS) score for wearing comfort, in which 0 implies no comfort. and 10 implies extremely comfortable.
Day 1, day 3 and 7 for part 1. Week 1, week 2 and week 5 for part 2

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Redislocation
Time Frame: Week 1, week 2 and week 5 (only part 2)

Redislocation is determined by the radiologic outcome:

  • Dorsal tilt > 15˚ on lateral X-ray
  • Volar tilt >20˚ on lateral X-ray
  • Shortening >5mm pertaining to the ulna in PA direction
  • Intraarticular step-off ≥ 2mm
  • Radial inclination < 15˚ in PA direction
  • Subluxation of the lunate According to guidelines on these parameters, redislocation is diagnosed.
Week 1, week 2 and week 5 (only part 2)
Pain Level
Time Frame: Day 1, day 3 and 7 for part 1. Week 1, week 2 and week 5 for part 2
Pain level caused by the brace will be determined using a 10-centimeter Visual Analog Scale (VAS), in which 0 implies no pain and 10 implies the worst possible pain.
Day 1, day 3 and 7 for part 1. Week 1, week 2 and week 5 for part 2
Inconvenience
Time Frame: Day 1, day 3 and 7 for part 1. Week 1, week 2 and week 5 for part 2
Inconvenience during activities of daily living using the Katz Index. The Katz Index asks for limitations in washing, clothing, indoor transfers, toilet visit, continence and eating. The range for the Katz index is 0 to 6 where 6 indicates full function, 4 indicates moderate impairment and 2 or less indicates severe functional impairment.
Day 1, day 3 and 7 for part 1. Week 1, week 2 and week 5 for part 2
Adverse reactions (pain, skin pressure, skin irritation/redness, sensibility issues or device-related problems
Time Frame: Day 1, day 3 and 7 for part 1. Week 1, week 2 and week 5 for part 2
Adverse reactions like pain, skin pressure, skin irritation/redness, sensibility issues, or device-related problems.
Day 1, day 3 and 7 for part 1. Week 1, week 2 and week 5 for part 2

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Age (calculated from date of birth and date of enrolment)
Time Frame: At baseline
- Age (calculated from date of birth and date of enrolment)
At baseline
Gender
Time Frame: At baseline
- Gender (male or female)
At baseline
ASA class
Time Frame: At baseline
- ASA class (1, 2, 3 of 4), assessed in a face-to-face interview
At baseline
BMI (calculated from height and weight)
Time Frame: At baseline
- BMI (calculated from height and weight)
At baseline
Tobacco consumption
Time Frame: At baseline
- Tobacco consumption (current, ever, never) was assessed in a short face-to-face interview
At baseline
Alcohol consumption
Time Frame: At baseline
- Alcohol consumption at enrolment (yes or no), assessed in a face-to-face interview
At baseline
Comorbidities including osteoporosis
Time Frame: At baseline
- Comorbidities including osteoporosis were assessed from the electronic patients dossiers
At baseline
Medication use
Time Frame: At baseline
Medication use was assessed through the electronic patient dossiers
At baseline
Dominant side (left or right)
Time Frame: At baseline
Dominant side was assessed in a face-to-face interview
At baseline
Affected side (part 2 only)
Time Frame: At baseline
- Affected side (left or right) was assessed by the clinician
At baseline
Trauma mechanism (low energy/high energy trauma or unknown)
Time Frame: At baseline
- Trauma mechanism (low energy fall or other, high energy trauma, or unknown) was assessed through face-to-face interview
At baseline
Additional injuries (yes or no, with specification)
Time Frame: At baseline

Additional injuries were assessed in a face-to-face interview

  • Trauma mechanism (low energy fall or other, high energy trauma, or unknown)
  • Additional injuries (yes or no, with specification)
  • Fracture classification (AO type 23-A, B or C)
At baseline
Fracture classification (AO type 23-A, B or C)
Time Frame: At baseline
- Fracture classification (AO type 23-A, B or C) was diagnosed by the clinician
At baseline
Date of scanning
Time Frame: At baseline
Date of scanning was documented by the clinician
At baseline
Date of brace fitting
Time Frame: At baseline
Date of brace fitting was documented by the clinician.
At baseline
Date of brace removal
Time Frame: At baseline
Date of brace removal was documented by the clinician. If brace was removed early, it was documented how treatment was continued (in patients only).
At baseline
Adherence to intervention
Time Frame: At baseline
Adherence to the intervention was checked (yes/no) and reasons for not adhering were documented by the clinician
At baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2017

Primary Completion (Actual)

June 1, 2018

Study Completion (Actual)

July 1, 2018

Study Registration Dates

First Submitted

February 13, 2019

First Submitted That Met QC Criteria

February 18, 2019

First Posted (Actual)

February 21, 2019

Study Record Updates

Last Update Posted (Actual)

February 22, 2019

Last Update Submitted That Met QC Criteria

February 20, 2019

Last Verified

February 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • Nl61002.078.17

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dorsal Displacement

Clinical Trials on Distal radius fracture brace

3
Subscribe